Operating Models for Regulated Clinical AI at Scale: From Pilot Systems to Auditable Production-Grade Deployment

Clinical artificial intelligence (AI) has demonstrated strong performance in controlled research and pilot settings, yet most clinical AI systems fail to scale into durable, production-grade deployments. In regulated healthcare environments, technical performance alone is insufficient; success depends on operating models that integrate regulatory constraints, clinical workflows, organizational accountability, and lifecycle governance into system design. While existing regulatory guidance (e.g., FDA and IMDRF Good Machine Learning Practice), quality standards (e.g., ISO 13485/14971), and MLOps paradigms provide necessary principles, they often stop short of defining how those principles are executed as an organizational operating system. This paper proposes an end-to-end operating model for regulated clinical AI, grounded in real-world deployment experience across diagnostic and enterprise healthcare environments. The model extends beyond model-centric or compliance-only approaches by explicitly linking governance structures, technical lifecycle management, and clinical workflow integration to decision rights and accountability. Regulation, auditability, and risk management are treated as foundational design inputs rather than downstream constraints. The framework comprises four interdependent layers: governance and decision rights; technical lifecycle management from development through post-market monitoring; clinical integration with adaptive human-in-the-loop (HITL) controls that evolve from pilot deployment to scaled operations; and continuous performance, safety, and economic feedback loops. Together, these layers define the organizational operating system required to sustain clinical AI safely, auditably, and economically at scale.